In our study, we demonstrate that the ATP-binding ability of ATAD3A strictly regulates the ATAD3A-ERK1/2 signaling axis and enables its role in favor of HNSCC growth by overexpressing WAK358A. Here, ATAD3A is linked to head and neck squamous cell carcinoma.